Remote Monitoring

Remote cardiac monitoring technologies enable patient health to be tracked outside the clinical setting. It can be used for longer term monitoring to help diagnosis arrhythmias or other cardiac conditions. Remote monitoring also can keep tabs on chronic conditions such as heart failure or hypertension and alert clinicians to worsening symptoms to avoid an acute care episode or hospitalization.

The U.S. Food and Drug Administration (FDA) cleared a smart watch artificial intelligence (AI) algorithm that tells wearers if they are suspected of having hypertension, which is expected to help notify about 1 million users over the next year. This a is a new feature of the newly launched Apple Watch Ultra 3, which the company unveiled Sept. 9. Apple gained FDA for its Cardiovascular Machine Learning-Based Notification Software Hypertension Notification Feature (HTNF) Sept. 11, 2025.

FDA clears Apple Watch algorithm for detecting hypertension

The FDA’s decision arrived just days after Apple announced the new feature. "This tool empowers patients and clinicians to work together, putting prevention at the center of care," one cardiologist told Cardiovascular Business. 

The Dexcom G7 Continuous Glucose Monitoring System

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately

The FDA has categorized this as a Class I recall. If patients update their phone or watch apps as needed, they can continue to use these devices like normal.

The new Apple Watch Ultra 3 offers a groundbreaking hypertension notifications alert users if signs of hypertension are detected using data from its optical heart sensor to analyze how a user’s blood vessels respond to heart beats. The algorithm works passively in the background, reviewing data over 30-day periods, and will notify users if it detects consistent signs of hypertension.

New Apple Watch Ultra 3 makes early hypertension detection a priority

"This tool empowers patients and clinicians to work together, putting prevention at the center of care," said Ami B. Bhatt, MD, ACC chief innovation officer. "What we really want to do is create patient agency and reach as many people as we can for earlier detection of high blood pressure."

Philips introduced a new cardiac monitoring telemetry platform designed to help address critical challenges in healthcare, including staff shortages and alarm management. A key component of the solution is the next-generation Telemetry Monitor 5500 is an integrated central monitoring unit solution that integrates the telemetry device platform.

Philips launches smart telemetry platform for cardiac monitoring

Care teams can face alarm and cognitive overload, with an average of 350 alarms going off per patient per day. But Philips' new telemetry platform streamlines alarm management, delivers data-driven insights and automates clinical tasks—with operational simplicity and networking options.

Thumbnail

Researchers use wearable fitness trackers to monitor sleep, CVD risk

A new two-year study is focused on the potential of using commercially available fitness trackers to identify patients who may face an increased risk of CVD.

Healthcare IT analyst Amy Thompson from Signify Research explains trends in cardiology information systems at ACC 2025.

Cardiovascular IT systems keep evolving with AI, Epic integration on the rise

A Signify Research representative highlights key trends in cardiovascular IT systems, including the growing role of AI and much more. 

Cardiosense CardioTag

FDA clears wearable heart device that captures multiple signals at once

The newly approved device captures electrocardiogram, photoplethysmogram and seismocardiogram signals at the same time. It can also be paired with advanced AI models to monitor patients for specific conditions.

Thumbnail

ICD patients may experience fear, anxiety or depression due to their devices

Some patients feel anxiety due to the risk of being shocked. Others have device recalls and/or cybersecurity threats on their mind.